Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cells |
| |
Authors: | Altmann Stephen M Muryshev Andrey Fossale Elisa Maxwell Michele M Norflus Francine N Fox Jonathan Hersch Steven M Young Anne B MacDonald Marcy E Abagyan Ruben Kazantsev Aleksey G |
| |
Institution: | Massachusetts General Institute for Neurodegenerative Disease and Harvard Medical School, Department of Neurology, Massachusetts General Hospital, Charlestown, 02129, USA. |
| |
Abstract: | Poly (ADP-ribose) polymerase (PARP1) is a nuclear protein that, when overactivated by oxidative stress-induced DNA damage, ADP ribosylates target proteins leading to dramatic cellular ATP depletion. We have discovered a biologically active small-molecule inhibitor of PARP1. The discovered compound inhibited PARP1 enzymatic activity in vitro and prevented ATP loss and cell death in a surrogate model of oxidative stress in vivo. We also investigated a new use for PARP1 inhibitors in energy-deficient cells by using Huntington's disease as a model. Our results showed that insult with the oxidant hydrogen peroxide depleted cellular ATP in mutant cells below the threshold of viability. The protective role of PARP1 inhibitors against oxidative stress has been shown in this model system. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |